All about PCR Peripheral 2016
PCR Peripheral Course addresses the clinical and technical challenges in peripheral endovascular treatment strategies. PCR Peripheral 2016 has been approved as COMPLIANT with the Eucomed Code of Ethical Business Practice. Find out more about the Course accreditation by the European Board for Accreditation in Cardiology (EBAC).
What makes this Course unique?
Step out of your daily work environment, the world is full of physicians similar to you. It is certainly rewarding to take a step back from the day-to-day grind and to share and debate your ideas. Each year at PCR Peripheral partnerships are forged, research projects are born and career opportunities are created.
Translate new scientific knowledge into meaningful advances in patient care. Stay up-to-date with techniques, devices, trials and the latest controversies to generate consensus from our community. You have four days away from the cathlab, use this opportunity to learn from the best.
They are all here: 120+ companies from the pharmaceutical industry to device and equipment manufacturers. Their best representatives are at PCR Peripheral. Discover their new products and R&D projects. Share your needs and opinions with them - interaction between practitioners and industry partners is crucial to the future developments & innovation in the field.
Eucomed represents the medical technology industry in Europe. Their mission is to make modern, innovative and reliable medical technology available to more people. Eucomed members include both national and pan-European trade and product associations as well as medical technology manufacturers.
PCR Peripheral 2016 has been approved as COMPLIANT with the Eucomed Code of Ethical Business Practice. The overall appropriateness of the conference for sponsorship of Healthcare Professionals by Eucomed members has been assessed as fully compliant.
Please contact Europa Group
Tel: +33 (0)5 34 45 26 45
To consult the EBAC Accreditation and to download your Attendance certificate please click here.